Globus Medical, Inc. (GMED) vs Bio-Techne Corporation (TECH)
A side-by-side comparison of Globus Medical, Inc. and Bio-Techne Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of August 28, 2026. Differences are shown without an overall score or investment verdict.
GMED
Globus Medical, Inc.
$82.54HealthcareDelayed quote: Aug 27, 2026, 4:00 PM EDT
TECH
Bio-Techne Corporation
$72.47HealthcareDelayed quote: Aug 27, 2026, 4:00 PM EDT
Total return — GMED vs TECH
growth of $100 · dividends reinvested · last 10yGMED +257.6% (+13.6%/yr)TECH +194.1% (+11.4%/yr)GMED compounded faster over this window
GMED TECH
GMED vs TECH: by the numbers
- •TECH is the larger company ($11.35B vs $11.13B market cap).
- •GMED trades at the lower trailing earnings multiple (21.22 vs 62.47 P/E), one valuation lens rather than an overall verdict.
- •GMED converts more revenue to profit (17.03% vs 14.97% net margin).
- •GMED grew revenue faster over the past five years (27.65% vs 5.47% CAGR).
- •TECH pays a dividend (0.44% yield), while GMED has no payments in the available dividend history.
Metrics side by side
Valuation
| Metric | GMED | TECH |
|---|---|---|
| P/E ratio | 21.22 | 62.47 |
| Forward P/E | 16.57 | 37.68 |
| P/S ratio | 3.63 | 9.36 |
| P/B ratio | 2.39 | 5.40 |
| EV / EBITDA | 11.79 | 32.65 |
| FCF yield | 6.58% | 2.31% |
Profitability
| Metric | GMED | TECH |
|---|---|---|
| Gross margin | 68.55% | 65.77% |
| Operating margin | 20.75% | 20.73% |
| Net margin | 17.03% | 14.97% |
| ROE | 11.23% | 8.63% |
| ROIC | 10.49% | 7.86% |
Dividends
| Metric | GMED | TECH |
|---|---|---|
| Dividend yield | N/A | 0.44% |
| Payout ratio | N/A | 27.35% |
Growth (annualized)
| Metric | GMED | TECH |
|---|---|---|
| Revenue CAGR (5Y) | 27.65% | 5.47% |
| EPS CAGR (5Y) | 30.79% | 5.16% |
| FCF CAGR (5Y) | 29.93% | -3.08% |
| Total return CAGR (5Y) | 0.22% | -9.72% |
Frequently asked
- Which has the lower trailing P/E, GMED or TECH?
- GMED has the lower trailing P/E: GMED trades at 21.22 and TECH at 62.47. P/E is one valuation measure and does not by itself establish which business is cheaper.
- Which has grown faster, GMED or TECH?
- Over the past five years, GMED grew revenue faster — GMED at a 27.65% CAGR versus TECH at 5.47%.
- Does GMED or TECH pay a bigger dividend?
- TECH pays a dividend (0.44% yield), while GMED has no payments in the available dividend history.
- Is GMED or TECH more profitable?
- GMED runs the higher net margin — GMED at 17.03% versus TECH at 14.97%.
- How have GMED and TECH total returns compared?
- Over the past 10 years, GMED delivered 13.76% and TECH delivered 11.28% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Globus Medical P/E ratioBio-Techne P/E ratioBio-Techne dividend yieldGlobus Medical ROEBio-Techne ROEGlobus Medical operating marginBio-Techne operating marginGlobus Medical revenue growthBio-Techne revenue growthGlobus Medical free cash flowBio-Techne free cash flow
Globus Medical & Bio-Techne appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified August 28, 2026.